FlowEighteen38 is a new brand of the FairJourney Biologics group born to facilitate and accelerate antibody projects by delivering purified proteins and/or characterisation data of antibody panels and of lead candidates. This is complementary to our mammalian display and phage display discovery platforms and will further reduce risk for our partners by selecting the right antibody lead for cell line development and manufacturing
FairJourney Biologics and IONTAS combined capabilities in 2020 as a fee for service antibody discovery company. The combined operations allow a complete offering around antibody discovery. Uses fully validated naïve libraries with parallel immune approaches and the unrivalled mammalian display technology to optimise antibody discovery research. The team of more than 100 scientists, anchored in a high-profile network of advisors, has successfully completed more than 500 projects, with over 100 biotechnology and pharmaceutical companies.
View our technologies